# Transferrin-dependent uptake and distribution of iron in osteoclast-like cells

**Authors:** Silvia Dolder, Romina Cabra, Jonas Zaugg, Giuseppe Albano, Daniel G. Fuster, Christiane Albrecht, Willy Hofstetter

PMC · DOI: 10.1016/j.bonr.2026.101909 · 2026-02-25

## TL;DR

This study shows how iron is taken up and stored in osteoclast-like cells, revealing that iron-starved cells absorb more iron, and that transferrin helps retain iron in these cells.

## Contribution

The study reveals novel insights into iron uptake mechanisms and storage pools in osteoclasts under iron-deficient conditions.

## Key findings

- Iron-starved osteoclasts take up more iron compared to iron-saturated cells.
- Transferrin-mediated iron remains in cells, forming stable pools while non-transferrin iron is lost quickly.
- Iron does not traffic to ferritin or mitochondria in osteoclasts during the study period.

## Abstract

Iron is an essential micro component and is involved in numerous critical cellular processes and in energy production. While its roles in oxygen transport and in oxidative phosphorylation are well documented, it remains to be elucidated, whether iron modulates specific cellular processes in different organs. Iron deficiency has been found to lead to a decrease in the capacity of osteoclasts to dissolve amorphous calcium phosphate. Furthermore, levels of iron in the cellular environment led to significant changes in the levels of transcripts encoding iron transport proteins. Within the present study, the uptake of iron by osteoclasts and the kinetics of intracellular transport were analyzed. For this purpose, M-CSF (Macrophage-Colony Stimulating Factor) dependent non-adherent osteoclast progenitor cells were differentiated to osteoclasts in media containing M-CSF and RANKL (Receptor Activator of NF-κB Ligand). For the upregulation of iron transport capacity, media were supplemented with Deferoxamine, an iron complexor, rendering the cultures virtually iron-free. To analyze iron uptake by osteoclast like cells, holo-transferrin, loaded with 55Fe was added to the cells and iron uptake was quantitated in whole cell lysates and in fractionated cells. The data demonstrates that Deferoxamine-treated osteoclasts absorb higher quantities of iron as compared to untreated control cells. By density gradient centrifugation, cell associated iron can be separated into two major pools. Pool I represents non-transferrin associated iron in cytoplasmic fractions, while pool II contains transferrin/ transferrin receptor associated iron. Within 4 h of incubation in iron-deficient medium, pool I disappears, as does transferrin. Pool II iron and transferrin receptor, however, remain detectable. Furthermore, iron peaks did not associate with ferritin nor with mitochondria, demonstrating that these two mechanisms of iron storage did not become activated during the course of the study. The data thus demonstrates that iron uptake by osteoclasts can be modulated by exogenous iron and that cell associated iron forms either a labile iron pool of free iron that is lost within a short period of time or a vesicular pool of non-transferrin bound iron that remains stable over the experimental period. No further trafficking of iron into ferritin particles or mitochondria was detected.

•Exogenous iron levels modulate levels of transferrin receptors in osteoclasts.•Iron-starved osteoclasts are more efficient in taking up iron than saturated osteoclasts.•Iron taken up by osteoclasts through a transferrin-mediated mechanism remains in the cells.•No iron trafficking to mitochondria or ferritin particles was observed in osteoclasts.

Exogenous iron levels modulate levels of transferrin receptors in osteoclasts.

Iron-starved osteoclasts are more efficient in taking up iron than saturated osteoclasts.

Iron taken up by osteoclasts through a transferrin-mediated mechanism remains in the cells.

No iron trafficking to mitochondria or ferritin particles was observed in osteoclasts.

## Linked entities

- **Proteins:** CSF1 (colony stimulating factor 1), TNFSF11 (TNF superfamily member 11), Tsf2 (transferrin 2), ferritin (soma ferritin-like)
- **Chemicals:** Deferoxamine (PubChem CID 2973), 55Fe (PubChem CID 26815), iron (PubChem CID 23925)

## Full-text entities

- **Genes:** Hfe (homeostatic iron regulator) [NCBI Gene 15216] {aka MR2}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Gusb (glucuronidase, beta) [NCBI Gene 110006] {aka Gur, Gus, Gus-r, Gus-s, Gus-t, Gus-u}, SLC11A2 (solute carrier family 11 member 2) [NCBI Gene 4891] {aka AHMIO1, DCT1, DMT1, NRAMP2}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, Tfr2 (transferrin receptor 2) [NCBI Gene 50765] {aka Trfr2}, Tnfsf11 (tumor necrosis factor (ligand) superfamily, member 11) [NCBI Gene 21943] {aka Ly109l, ODF, OPGL, RANKL, Trance}, CSF1 (colony stimulating factor 1) [NCBI Gene 1435] {aka CSF-1, MCSF, PG-M-CSF}, Trf (transferrin) [NCBI Gene 22041] {aka Cd176, HP, Tf, Tfn, hpx}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Itgav (integrin alpha V) [NCBI Gene 16410] {aka 1110004F14Rik, 2610028E01Rik, CD51, D430040G12Rik}, Tfrc (transferrin receptor) [NCBI Gene 22042] {aka 2610028K12Rik, CD71, E430033M20Rik, Mtvr1, TFR, TFR1}, EEA1 (early endosome antigen 1) [NCBI Gene 8411] {aka MST105, MSTP105, ZFYVE2}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Slc40a1 (solute carrier family 40 (iron-regulated transporter), member 1) [NCBI Gene 53945] {aka Dusg, Fpn1, IREG1, MTP, MTP1, Ol5}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Acp5 (acid phosphatase 5, tartrate resistant) [NCBI Gene 11433] {aka TRACP, TRAP}, Slc11a2 (solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2) [NCBI Gene 18174] {aka DCT1, DMT1, Nramp2, mk, van}, Golga1 (golgin A1) [NCBI Gene 76899] {aka 0710001G09Rik, 2210418B03Rik, Golgi97, awag, golgin-97}, Atp5f1a (ATP synthase F1 subunit alpha) [NCBI Gene 11946] {aka Atp5a1, Atpm, D18Ertd206e, Mom2}, Atp6v0d2 (ATPase, H+ transporting, lysosomal V0 subunit D2) [NCBI Gene 242341] {aka 1620401A02Rik, V-ATPase}
- **Diseases:** anemia (MESH:D000740), inflammatory (MESH:D007249), iron overload (MESH:D019190), osteoporosis (MESH:D010024), OC (MESH:D001862), organ damage (MESH:D000092124), hereditary hemochromatosis (MESH:D006432), Iron deficiency (MESH:D000090463)
- **Chemicals:** oxygen (MESH:D010100), penicillin (MESH:D010406), HEPES (MESH:D006531), NaHCO3 (MESH:D017693), 55FeCl3 (-), MgCl2 (MESH:D015636), TX-100 (MESH:C551282), S (MESH:D013455), NaCl (MESH:D012965), trichloroacetic acid (MESH:D014238), hydroxyapatite (MESH:D017886), FeCl3 (MESH:C024555), streptomycin (MESH:D013307), Deferoxamine (MESH:D003676), polyacrylamide (MESH:C016679), 55Fe (MESH:C000615387), EDTA (MESH:D004492), heme (MESH:D006418), sucrose (MESH:D013395), Fe (MESH:D007501), lipids (MESH:D008055), TBS (MESH:D013725), ATP (MESH:D000255), water (MESH:D014867), mannitol (MESH:D008353), reactive oxygen species (MESH:D017382), Pen (MESH:C058388), FT (MESH:D005641), KCl (MESH:D011189), DFO (MESH:C000709069), Tween (MESH:D011136), CaCl2 (MESH:D002122), alphaMEM (MESH:C420642), calcium phosphate (MESH:C020243), PBS (MESH:D007854), H+ (MESH:D006859)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** OC — Mus musculus (Mouse), Transformed cell line (CVCL_F699)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966646/full.md

---
Source: https://tomesphere.com/paper/PMC12966646